Characteristics of Idiopathic Familial Speech Disorders

According to studies, speech disorders with unknown causes (idiopathic) affect approximately 5% of the population at some point in their life. Some of these disorders like, stuttering and cluttering, are known for being detected early, during speech development.

Stuttering is characterized by sound and syllable repetitions and consonant/vowel prolongations. When stuttering is moderate to severe, it can interfere with a person's job and social activities.

Speech articulation disorders are characterized by omissions, or substitutions of speech sounds. The speech of a person who clutters is often difficult to understand. People are often unaware of the errors they make when speaking causing treatment of the condition to be very difficult.

The purpose of this research is to study an extended family whose members exhibit a pure form of speech articulation disorders

In addition, the study will use data and information gathered from the study and use it to develop guidelines (criteria) for defining and differentiating patients with speech disorders.

Study Overview

Detailed Description

Objective:

Our objective is to determine which factors are involved in the development of stuttering and familial phonological processing disorder and are associated with a familial pattern of inheritance.

Study population: The study population is comprised of 8 groups:

  1. Children and adults with persistent developmental stuttering;
  2. Unaffected siblings of the individuals affected with developmental stuttering or recovered from stuttering
  3. Children and adults who have recovered from developmental stuttering;
  4. Children and adults with persistent familial phonological processing disorders (FPPD);
  5. Unaffected siblings of the individuals affected with FPPD or have recovered from FPPD
  6. Children and adults who have recovered from FPPD;
  7. Unaffected siblings of the individuals who have recovered from FPPD;
  8. Children and adults with normal speech and language development who will comprise the control groups.

Design: A Natural history design will be used to compare affected and unaffected family members with healthy volunteers with normal speech and language.

Outcome Measures: Genetic markers and pedigree analyses will be used to test familial inheritance patterns. Speech and language development will be compared using indices of speech perception, auditory perception, self monitoring of one's own speech, language complexity, motor complexity, speech learning, phonological processing and verbal/nonverbal memory.

Study Type

Observational

Enrollment

375

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • College Park, Maryland, United States
        • University of Maryland, College Park
    • Wisconsin
      • Madison, Wisconsin, United States, 53792
        • University of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

-INCLUSION CRITERIA:

i. Normal Language Development, Hearing and Cognition

ii. The following screening tests previously published with norms were found to have a good distribution for determining normal functioning in adolescents and adults as all subjects did not hit ceiling and all had scores greater than or equal to the 80th percentile. These tests are being used to ensure that subjects affected with stuttering or FPPD do not have other disorders such as hearing loss, language delay, or mental retardation.

Peabody Picture Vocabulary Test III (PPVT-III)

Expressive Vocabulary Test (EVT)

Oral Speech Mechanism Screening Examination

Revised Token Test; Token test for Children

Test of Non verbal intelligence (TONI-2)

Digit Span subtest of the WICS-R

Audiometric Screening

Goldman Fristoe Test of Articulation

WUG Test of Morphological Encoding

Test of Auditory Comprehension of Language (TACL)

Khan-Lewis Phonological Analysis

INCLUSION CRITERIA FOR IDENTIFYING AND QUANTIFYING STUTTERING:

The Stuttering Severity Index -3 (Riley, 1981) has been found to be accurate for identifying and assessing the severity of stuttering during conversational speech. For the inclusion of a stuttering subject we require:

i. A total overall score of 11 or greater between 3 and 17 years,

ii. A total overall score of 18 or greater from age 18 and above.

INCLUSION CRITERIA FOR IDENTIFYING FPPD:

i. A family history of an autosomal dominant pattern of inheritance of the speech disorder over several generations with persistence into adulthood in some cases,

ii. Speech symptoms during conversational speech include: deletion of final consonants; syllable reduction and syllable deletion; deletion of grammatical markers such as copulas, auxiliaries, prepositions, connectives; poor ability to self-correct; poor awareness of errors; and consonant cluster reduction.

iii. Greater than 9% discourse errors during analysis of a sample of 300 syllables.

iv. A discrepancy of 30 points (1 and 1/2 Standard Deviations) between receptive (the higher score) and expressive percentile score on the PPVT III and Expressive Vocabulary Test.

v. For subjects greater than 7 years of age, a phonological process rating of 3 or more for any phonological process on the Khan-Lewis Phonological Analysis. For subjects less than 7 years of age, a phonological process rating of 3 or more on 2 phonological processes on the Khan-Lewis Phonological Analysis. Finally, any subjects with a non developmental phonological process error will be identified as potentially having FPPD.

EXCLUSION CRITERIA:

i. Anyone with a hearing loss will be excluded from participation during the diagnostic testing.

ii. Children with delayed language, more than 1 year delay from norms on receptive and expression language testing will be excluded.

iii. Language impairment: scores more than 2 standard deviations below the age appropriate score on the standardized language tests listed under the inclusion criteria.

iv. Cognitive impairment: scores more than 2 standard deviations below the age appropriate score on the standardized cognitive tests listed under the inclusion criteria.

v. Bilingual non-native English speakers - Studies have demonstrated that brain organization for speech and language may differ in bilingual persons. It is hypothesized that this may alter speech motor learning and thus kinematic data from non-native English speakers would differ from native English speakers. Therefore, only native-American English speakers, with only one language spoken in the home, will be included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 22, 1996

Primary Completion (ACTUAL)

November 13, 2009

Study Registration Dates

First Submitted

November 3, 1999

First Submitted That Met QC Criteria

November 3, 1999

First Posted (ESTIMATE)

November 4, 1999

Study Record Updates

Last Update Posted (ACTUAL)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 30, 2017

Last Verified

November 13, 2009

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stuttering

3
Subscribe